Spencer K Sullivan MD
Pediatric Anemia and Red Blood Cell Hematology, Pediatric Coagulation Disorder Hematology, Pediatric Platelet Disorder Hematology
CEO, Mississippi Center for Advanced Medicine
Join to View Full Profile
7730 Old Canton RdBldg BMadison, MS 39110
Phone+1 601-499-0935
Fax+1 601-499-0936
Dr. Sullivan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2009 - 2012
University of Virginia Medical CenterFellowship, Blood Banking/Transfusion Medicine, 2008 - 2009- University of Virginia Medical CenterResidency, Pediatrics, 2005 - 2008
University of North Carolina at Chapel Hill School of MedicineClass of 2005
Certifications & Licensure
LA State Medical License 2020 - 2025
MS State Medical License 2014 - 2025
TN State Medical License 2021 - 2024
AL State Medical License 2022 - 2022
PA State Medical License 2009 - 2014
VA State Medical License 2005 - 2010
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- LTFU for Gene Transfer Subjects With Hemophilia B Start of enrollment: 2007 Aug 01
- A Gene Therapy Study for Hemophilia B Start of enrollment: 2015 Nov 18
- A Gene Transfer Study for Hemophilia A Start of enrollment: 2017 Jan 26
- Join now to see all
Publications & Presentations
PubMed
- 99 citationsMultiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A.Lindsey A. George, Paul E Monahan, M Elaine Eyster, Spencer K. Sullivan, Margaret V Ragni
The New England Journal of Medicine. 2021-11-18 - 10 citationsInfused factor VIII-expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia A.Randolph B. Lyde, Hyun Sook Ahn, Karen K. Vo, Danuta Jarocha, John Tkaczynski
Blood Advances. 2019-05-14 - 464 citationsHemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.Lindsey A. George, Spencer K. Sullivan, Adam Giermasz, John E.J. Rasko, Benjamin J. Samelson-Jones
The New England Journal of Medicine. 2017-12-06
Press Mentions
Gene Therapy SPK-8016 Shows Early Promise for Severe Hemophilia AFebruary 8th, 2021
Spark Therapeutics Announces Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX ActivityJune 13th, 2016
External Links
- MCAM Websitehttp://www.msadvancedmedicine.com
- MCAM Facebookhttps://www.facebook.com/MississippiAdvancedMedicine/?ref=bookmarks
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
